Hm Payson & CO Biogen Inc. Transaction History

Hm Payson & CO

$5.81 Billion
Q3 2024

A detailed history of Hm Payson & CO transactions in Biogen Inc. stock. As of the latest transaction made, Hm Payson & CO holds 1 shares of BIIB stock, worth $150. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$150

% of portfolio

0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$189.07 - $236.8 $189 - $236	1 New	1 $0
Q3 2023 Nov 06, 2023	BUY	$253.3 - $285.89 $50,660 - $57,178	200 Added 400.0%	250 $64,000
Q1 2023 Apr 18, 2023	SELL	$256.56 - $292.34 $65,422 - $74,546	-255 Reduced 83.61%	50 $13,000
Q4 2022 Feb 06, 2023	BUY	$252.44 - $306.72 $1,262 - $1,533	5 Added 1.67%	305 $84,000
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $1,312 - $1,561	-7 Reduced 2.28%	300 $61,000
Q1 2022 May 12, 2022	BUY	$193.77 - $244.14 $1,356 - $1,708	7 Added 2.33%	307 $65,000
Q2 2021 Aug 17, 2021	SELL	$259.0 - $414.71 $6,216 - $9,953	-24 Reduced 7.41%	300 $104,000
Q1 2021 Jun 15, 2021	BUY	$242.95 - $284.63 $5,830 - $6,831	24 Added 8.0%	324 $91,000
Q1 2020 Jul 01, 2020	SELL	$268.85 - $341.04 $17,475 - $22,167	-65 Reduced 17.81%	300 $95,000
Q3 2019 Nov 12, 2019	SELL	$217.44 - $243.88 $135,682 - $152,181	-624 Reduced 63.09%	365 $85,000
Q2 2019 Aug 15, 2019	BUY	$219.29 - $241.72 $216,877 - $239,061	989 New	989 $231,000
Q4 2018 Feb 15, 2019	SELL	$278.5 - $352.75 $294,096 - $372,504	-1,056 Closed	0 $0
Q3 2018 Nov 30, 2018	SELL	$293.51 - $383.83 $11,153 - $14,585	-38 Reduced 3.47%	1,056 $373,000
Q2 2018 Aug 27, 2018	SELL	$257.52 - $306.91 $19,314 - $23,018	-75 Reduced 6.42%	1,094 $317,000
Q1 2018 May 14, 2018	BUY	$260.13 - $367.91 $14,047 - $19,867	54 Added 4.84%	1,169 $320,000
Q4 2017 Feb 16, 2018	BUY	$307.64 - $344.58 $33,532 - $37,559	109 Added 10.83%	1,115 $355,000
Q3 2017 Nov 06, 2017	BUY	$281.15 - $329.69 $282,836 - $331,668	1,006	1,006 $315,000

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

News

Stay updated on Hm Payson & CO with notifications on news.

Account